Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Petros Pharmaceuticals, Inc.US flagNASDAQ Capital Market
0.01
USD
- -
- -
155,801.00Market Cap

Petros Pharmaceuticals, Inc. (PTPI) Stock Splits

Learn about Petros Pharmaceuticals, Inc.'s most recent 1-for-25 basis stock split on May 01, 2025. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Petros Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2025-05-01
Split Ratio: 1:25
Price Before Split: $0.01
Price After Split: $0.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 25.00 times fewer shares (a 1:25 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Petros Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-05-011:25Yes$0.01$0.00
2022-12-011:10Yes$0.43$0.04

About Petros Pharmaceuticals, Inc.

Company overview and industry information

Petros Pharmaceuticals, Inc. (PTPI) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to Petros Pharmaceuticals, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.